IP Library Assignment 067057/0556
Patent Assignment
Reel/Frame 067057/0556

Assignment of Assignor's Interest

Recorded: 2024-04-10 Pages: 2
Assignor
PRESTIGE BIOPHARMA LIMITED
Executed: 2024-03-26
Assignee
PRESTIGE BIOPHARMA IDC CO., LTD.
11 FL., 44 MYEONGJIGUKJE 7-RO, GANGSEO-GU, BUSAN, 46726, KOREA, REPUBLIC OF
Covered Property (1)
Novel CTHRC1-Specific Antibody and Use Thereof
Application: 17/549,809 →
Publication: US 2022/0204599
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 6, 2022
From: SEOK KOH, SANG; KYUNG KANG, MIN; YEON PARK, SO
To: PRESTIGE BIOPHARMA PTE. LTD.
Reel/Frame 059837/0946 →
Change of Name Apr 10, 2024
From: PRESTIGE BIOPHARMA PTE. LTD.
To: PRESTIGE BIOPHARMA LIMITED
Reel/Frame 067057/0562 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 67057 Frame: 556. Assignor(S) Hereby Confirms the Assignment. Apr 23, 2024
From: PRESTIGE BIOPHARMA LIMITED
To: PRESTIGE BIOPHARMA LIMITED; PRESTIGE BIOPHARMA IDC CO., LTD.
Reel/Frame 067193/0670 →